Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Boileau, Jean-Francois; Poirier, Brigitte; Basik, Mark; M B Holloway, Claire; Gaboury, Louis; Sideris, Lucas; Meterissian, Sarkis; Arnaout, Angel; Brackstone, Muriel; R McCready, David; E Karp, Stephen; Trop, Isabelle; Lisbona, Andre; C Wright, Frances; J Younan, Rami; Provencher, Louise; Patocskai, Erica; Omeroglu, Atilla; Robidoux, Andre

doi:10.1200/JCO.2014.55.7827

Public

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Shared by NobleBlocks on Jan 20, 2015 • 12:00 AM UTC

Authors:

Jean-Francois Boileau

Brigitte Poirier

Mark Basik

Abstract

PURPOSE: An increasing proportion of patients (> 30%) with node-positive breast cancer will obtain an axillary pathologic complete response after neoadjuvant chemotherapy (NAC). If sentinel node (SN) biopsy (SNB) is accurate in this setting, completion node dissection (CND) morbidity could be avoide...

Discussions